Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrapleural TolueneSulfonamide for Malignant Pleural Effusion in NSCLC
NCT07332858Phase 2Recruiting
- Sponsor
- Gang Hou
- Start
- Apr 2026
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
A Phase 2 trial of para-toluenesulfonamide in malignant pleural effusion (MPE), sponsored by Gang Hou. Started Apr 2026; status: recruiting.
02
Drugs
para-toluenesulfonamide
03
Conditions
malignant pleural effusion (MPE)
Beyond the preview
Go deeper on NCT07332858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07332858.